FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...

The research group of prof. Sanjiv Luther at the department of immunobiology of the University of Lausanne has discovered ...

Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, fibroblast cells rush in to make fibronectin and collagen, which are two major ...

Study helps lay the foundations for a future of “smart” tissue therapeutics that can be scaled to a patient’s needs.

As we age, we don’t recover from injury or illness like we did when we were young. But new research from UC San Francisco has found gene regulators that turn genes on and off that could restore the ...

FibroBiologics, Inc., a clinical-stage biotechnology company focused on developing therapies for chronic diseases through fibroblasts, announced an investor webinar scheduled for July 10, 2025, at ...

Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...

Scientists at the University of Lausanne have identified a specialized fibroblast subtype that directs cytotoxic T lymphocytes to key positions within lymph nodes, enabling effective immune responses ...

In reading, a bookmark tells where you stopped. Cells use bookmarks too, specific proteins that help the cell remember what collection of genes needs to be turned on again after the brief halt of gene ...